Aspire Biopharma Holdings Inc. (ASBP)
Market Closed
30 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
6. 72
+1.11
+19.7861%
$
835.87K Market Cap
- P/E Ratio
- Div Yield
13,104 Volume
- Eps
$ 5.61
Previous Close 
Want to track ASBP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aspire Biopharma Holdings Inc. (ASBP) Statistics
Valuation metrics
Market Cap 835.87K
Enterprise value -3.52M
Trailing P/E (ttm) -0.86
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 24.24
Price/Book (mrq) 2.81
Enterprise Value/Revenue -101.87
Enterprise Value/EBITDA -0.82
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 69.78K
Average volume (90 days) 850.92K
Price summary
52-Week low 0.11
52-Week high 35
Beta -
50-Day moving average 7.1
200-Day moving average 33.72
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 11 May 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -340.4%
Operating margin -157.46%
Operational effectiveness
Return on assets -1.65%
Return on equity 1.99%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.92
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 2.26%
Book value per share (mrq) 2.59
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
